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By Jussi Taipale1,2,3 
D
evelopments in modern genomics 
tools have led to rapid progress in our 
understanding of the genetic basis 
of cancer. Recent large-scale efforts 
have primarily focused on two types 
of analysis: mapping acquired so-
matic mutations by whole-exome and whole-
genome sequencing (1, 2), and identification 
of common inherited variants that increase 
cancer risk using genome-wide association 
studies (GWAS) (3). Despite the power of 
these technologies, we are still far from un-
derstanding how the variants and mutations 
found in individual tumors precisely drive 
the oncogenic process. A large number of 
genetic variants increase risk for cancer, but 
most explain only a very small fraction of the 
risk. Furthermore, although acquired somatic 
mutations are found in almost all tumors, 
most do not carry complete sets of mutations 
that, according to our present mechanistic 
understanding, would be sufficient to cause 
cancer. On page 420 of this issue, Corces et 
al. (4) show how a third type of genomics 
approach—functional genomic analyses of 
primary human tumors—can begin to bridge 
this gap in our mechanistic understanding of 
the tumorigenic process. 
The authors analyzed chromatin accessi-
bility using ATAC-seq (assay for transposase-
accessible chromatin using sequencing) of 
410 primary tumors representing 23 different 
types of human cancer. Analysis of chroma-
tin accessibility measures stable binding 
of proteins to the genome; regions that are 
unbound are  accessible to enzymes such as 
deoxyribonuclease I (DNase I) (5) or Tn5 
transposase (4). The ATAC-seq method used 
by Corces et al. utilizes Tn5, which inserts a 
linker sequence to accessible DNA and cuts 
it, allowing highly efficient isolation and se-
quencing of the liberated fragments. Most of 
the human genome is relatively inaccessible 
because it is wound around histone proteins, 
forming nucleosomes, each of which contains 
147 base pairs of DNA. In less than 1% of the 
genome, the histones are replaced by other 
proteins that regulate chromosome structure, 
or that function as transcription factors to 
direct gene expression. Tn5 can insert DNA 
linkers between such proteins; if the proteins 
are bound tightly, their binding position also 
leaves a “footprint” that is narrower than that 
formed by a nucleosome. DNA accessibility is 
known to correlate with the presence of ac-
tive gene regulatory elements such as pro-
moters and enhancers, and is thus commonly 
used as a proxy for gene regulation. Motif 
mining of the accessible regions and analysis 
of sequences under the footprints can then 
be used to infer which sequence-specific DNA 
binding proteins are bound to the accessible 
regions. The power of the approach of Corces 
et al. derives from the combination of deep 
sequencing that allows footprinting with the 
analysis of a large number of samples repre-
senting different types of cancer. Importantly, 
the samples used are sequenced for muta-
tion mapping in The Cancer Genome Atlas 
(TCGA) project, facilitating comparative mul-
tiomic analyses between different data types.
The motif mining and footprinting analy-
ses reveal many transcription factors that are 
strongly active in the different cancer types. 
For example, the authors detect androgen 
receptor in prostate cancer and microphthal-
mia-associated transcription factor (MITF) 
in melanoma, indicating that ATAC-seq can 
pinpoint known cancer type–specific tran-
scription factors. The identification of acces-
sible chromatin across multiple cancer types, 
together with detection of expressed genes 
by RNA sequencing, allows inference of DNA 
elements that may regulate gene expression 
(5). This analysis is based on correlation, but 
the authors also validate a subset of the po-
tential enhancer-promoter links by targeting 
a repressor to the regulatory elements using 
CRISPR-Cas9 interference. Compared to 
RNA sequencing, the analysis of accessible 
chromatin also gives a more detailed “finger-
print” of the tissue, facilitating classification 
of tumors and analysis of their cellular com-
position. The chromatin accessibility data 
can also be used to locate elements that con-
tain variants that may contribute to inherited 
cancer risk, and to identify somatic noncod-
ing mutations that affect chromatin accessi-
bility. Given the scale of the dataset and its 
multiomic character, there is great potential 
for new discoveries. Most of the individual 
findings reported by Corces et al. need fur-
ther validation. However, the large number of 
interesting initial discoveries, such as the link 
between elements near the MECOM gene and 
adverse outcome in kidney cancer, highlights 
the value of the dataset as a reference and as 
a data-mining resource for future studies.
The analysis of chromatin accessibility in 
primary tumor cells also extends the known 
repertoire of potential gene regulatory el-
ements. Of those identified by Corces et al., 
35% were not previously known. Many of the 
elements identified from primary tumors are 
likely to be important for normal develop-
mental and homeostatic processes. However, 
there is good reason to suspect that at least 
some may not be so benign. Our genome is 
likely to encode a large number of potentially 
pathological transcription factor–DNA inter-
actions (6, 7). This is because cancer-causing 
mutations can directly affect transcription 
factor binding sites, leading to activation of 
normally silent regulatory elements (8). Mu-
tations can also activate transcription factors 
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Sequence and function  of 
the cancer genome 
Multiomic mapping and comparison between 
genetic and epigenetic features are required for 
mechanistic understanding of cancer and for 
providing a “fingerprint” of the tumor. Multiomic 
analyses are likely to be important for cancer 
diagnosis and prediction of outcome, as well as for 

















Coastal habitats  represent




ertebrates encompass all animals 
with a backbone, from fish to hu-
mans. How and when they evolved 
are questions that have been studied 
for centuries, revealing the origins 
and processes involved in anatomical 
innovations such as jaws, teeth, and paired 
appendages (1). A less explored, but equally 
important question is where they evolved. 
On page 460 of this issue, Sallan et al. (2) 
compile a new database of early occur-
rences (mid-Paleozoic, 490 to 360 million 
years ago) and site-specific environmental 
information to reconstruct vertebrate an-
cestral habitats. They report that all major 
vertebrate clades originated in restricted, 
shallow-water environments. 
The environmental context of vertebrate 
evolution had remained a gap in our knowl-
edge. Understanding the habitat constraints 
present when key traits evolved is neces-
sary to answering fundamental questions 
in macroevolution such as the extent to 
which the environment can drive anatomi-
cal transformations. Reaching this level of 
understanding has been limited mostly by a 
lack of data in available compendia (3). The 
examination of primary data on early fish 
(e.g., from the mid-Paleozoic) revealed that 
their fossil record accumulated in shallow 
waters (4). However, it has been recognized 
that this might be an artifact of a poor fos-
sil record; in other words, the habitats from 
where ancient fish have been recovered 
might reflect outcrop (the exposure of rocks) 
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that have low or no activity in the correspond-
ing normal tissues, leading to activation of 
large sets of gene regulatory elements (9). In 
addition, many driver mutations affect chro-
matin modifiers or alter levels of CpG meth-
ylation of DNA, leading to destabilization of 
the entire chromatin regulatory system (1, 
2). It is difficult for evolutionary processes to 
remove large sets of potentially harmful ele-
ments from our genome, as each individual 
element has limited impact at the population 
level, and cancer generally affects individuals 
who are above reproductive age. Therefore, it 
is likely that elements that are specifically ac-
tivated in cancer are present in our genome. 
Identification of such elements will facilitate 
improved diagnosis and prognosis, and also 
allow investigations of new therapeutic mo-
dalities to target oncogenic gene regulation. 
The mapping of accessible chromatin 
landscapes is also important for the mech-
anistic understanding of tumorigenesis. It is 
known that altered activities of transcription 
factors and/or their binding regions drive 
the major forms of human cancer. Cancer 
can thus be considered a disease of gene ex-
pression, where a combination of mutations 
locks the gene regulatory network of a sin-
gle cell into a state that drives unrestricted 
cell proliferation (6). Although mutations 
in some oncogenes and tumor-suppressor 
genes are commonly found across many 
forms of cancer, most driver genes are mu-
tated in a more restricted set of tumors. 
Some of the differences in oncogene com-
position can be explained by differences in 
mutational mechanisms and proto-oncogene 
expression between the cell types of origin of 
the tumors. However, many oncogenes can-
not transform fibroblastic cells in standard 
cell-based assays, suggesting that cell line-
age–determining transcription factors col-
laborate in some way with oncogenes. The 
mechanisms of such collaboration are cur-
rently poorly understood, but given that lin-
eage-determining factors commonly define 
chromatin states, it is likely that accessibil-
ity of chromatin at specific regulatory sites 
contributes to this process. An important 
contribution of the study by Corces et al. is 
the identification of candidate sets of such 
lineage-specific regulatory elements that are 
critical for the cancer phenotype. 
Cancer genome sequencing efforts have 
revealed that a large number of genes can 
cause cancer. Because most of the driver 
genes are mutated infrequently, making 
mechanistic sense of the cancer genotype 
by straightforward genetic interaction anal-
ysis requires extremely large sample sizes. 
Combining genomic data with phenotypic 
information is thus an attractive alternative. 
Traditionally, there has been a disconnect 
between cancer genomics and large-scale 
efforts to map the functional genome. The 
Roadmap Epigenomics (10) and Genotype-
Tissue Expression (GTEx) (11) projects pri-
marily focus on normal tissues, whereas 
the main drive of ENCODE (5) is to iden-
tify functional genomic elements; although 
cancer cells are used as models in some of 
these projects, the cell lines used do not ad-
equately represent major forms of human 
cancer. Previous epigenomic studies of can-
cer, in turn, have mainly focused on targeted 
DNA methylation analysis (12), transcription 
factor binding analyses in a few cell lines 
(13), or analysis of histone modifications in 
a particular type of cancer (14). In this con-
text, the study by Corces et al. is particularly 
welcome because it paves the way toward a 
large-scale effort to map the functional ge-
nome of cancer cells. To understand how in-
dividual tumors form, it is necessary to map 
their genomic features such as germline var-
iants, somatic mutations, chromosomal con-
tent, and allelic imbalance (15), together with 
functional genomic features such as genes 
that are essential for growth and survival, 
three-dimensional (3D) chromosome con-
formation, the DNA methylome, chromatin 
modification state, and accessible chromatin 
landscape (see the figure). Comparing cancer 
types to each other can yield interesting re-
sults but suffers from the disadvantage that 
all cancers share key phenotypic character-
istics, such as unrestricted growth. A better 
comparison would be between cancers and 
their cell types of origin. However, the cell 
type of origin of many cancers is unknown, 
and many tumors are thought to originate 
from relatively rare cells (for example, stem 
or progenitor cells). Therefore, it will also 
be necessary to develop analytical methods 
that can detect genomic features from minor 
cell populations or from single cells. Without 
such multiomic maps at the cell-type level, 
it will be exceedingly difficult to move from 
genomics toward understanding the main 
drivers of the phenotype of individual tum-
ors. Without such understanding, we may 
not be able to conquer cancer. j
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“What was so special 
about the shallow-water 
habitats where 
vertebrates diversified?”
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